Clinical Trials Logo

Clinical Trial Summary

This prospective, sample collection study will assess different oral and/or nasal sample types collected from patients suspected of suffering from GABHS pharyngitis to conduct research and development on innovative GABHS detection methods specific for each sample type.


Clinical Trial Description

Study candidates are patients age 3 and older with complaints of sore throat and are suspected of suffering from GABHS pharyngitis. Patients who consent and are found eligible will be enrolled in the study. Subjects will be tested according to the conventional standard of care in addition to providing extra specimen samples for the study. After each patient has been tested according to conventional SOC and has enrolled in the study, up to ten oral and/or nasal specimen samples will be collected . Study participation is complete once all specimen samples are collected. Most or all collected samples will be qualitatively tested and may also be quantitatively and/or semi-quantitatively tested for the presence of GABHS. Some collected samples may additionally or alternatively be tested for other respiratory infections as well. (such as SARS-CoV-2, influenza, etc.) ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05223634
Study type Observational
Source Hero Scientific
Contact Robert Levitz
Phone +972.2.678.7342
Email rlevitz@heroscientific.com
Status Recruiting
Phase
Start date November 18, 2020
Completion date June 2022